INTRODUCTION
Inherited deficiency of surfactant protein-B (SP-B) is a fatal autosomal recessive disorder of lung cell metabolism that is characterized by rapidly progressive respiratory failure at birth.
1,2 A net two base-pair insertion in codon 121 of the SP-B gene (121ins2), the most common mutation associated with SP-B deficiency, creates a site for premature cessation of translation and leads to complete absence of mature SP-B and its precursor peptides. 3 Lung transplantation is the only successful intervention available for infants with SP-B deficiency. 4 However, the ability to achieve transplantation is dependent on the ability to accomplish adequate gas exchange and to prevent extrapulmonary organ dysfunction in the pretransplantation period.
Previous attempts to support SP-B-deficient infants using conventional ventilation were unsuccessful in maintaining extrapulmonary organ function. 1, 5, 6 While successfully supporting oxygenation and extrapulmonary organ function with high-frequency oscillatory ventilation (HFOV) of one SP-B-deficient infant who was awaiting lung transplantation, we noted that oxygenation and chest radiographic appearance improved during neuromuscular blockade, but deteriorated with HFOV alone. In addition, alveolar proteinosis, the histologic description applied to the earliest cases of SP-B deficiency, was absent on histologic examination of the explanted lungs. 4 Therefore, to determine if this response to HFOV and neuromuscular blockade was reproducible in infants with SP-B deficiency, we retrospectively evaluated oxygenation and chest radiographic appearance of SP-B-deficient infants who required HFOV and neuromuscular blockade.
METHODS

Subjects
For this case series, we retrospectively reviewed the medical records and chest radiographs of five infants homozygous for 121ins2 who received HFOV with intermittent neuromuscular blockade while awaiting lung transplantation between 1994 and 1998 (Table 1) . Neuromuscular blockade (pancuronium) was initiated at the discretion of the clinical team whenever deteriorating gas exchange failed to respond to increasing FiO 2 , mean airway pressure, or amplitude, and was discontinued once gas exchange stabilized. The clinical team made decisions regarding the type of ventilation and degree of support. Data extracted from the records included the type and degree of ventilation, blood gases, and the
OBJECTIVE:
To determine if high -frequency oscillatory ventilation and neuromuscular blockade improve oxygenation and chest radiographic appearance more effectively than high -frequency oscillation alone for surfactant protein -B ( SP -B ) -deficient infants.
STUDY DESIGN:
We reviewed medical records and chest radiographs of five SP -B -deficient infants awaiting lung transplantation. Changes in FiO 2 and radiographic scores were analyzed with respect to neuromuscular blockade status.
RESULTS:
FiO 2 consistently increased 0.20 (SD 0.11) during high -frequency ventilation without neuromuscular blockade ( p = 0.02 ) and decreased 0.14 (SD 0.11) during high -frequency ventilation with neuromuscular blockade ( p = 0.05 ). Chest radiographic appearance, quantified by an expansion / aeration index, consistently deteriorated without neuromuscular blockade ( p = 0.01 ) and consistently improved with neuromuscular blockade ( p = 0.03 ). Changes in FiO 2 correlated with changes in radiograph scores ( r = 0.7, p < 0.001 ).
CONCLUSIONS:
High -frequency ventilation with neuromuscular blockade optimizes oxygenation for SP -B -deficient infants. This ventilatory strategy should be considered while awaiting the diagnosis of SP -B deficiency or lung transplantation. 
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administration of neuromuscular blocking agents and corticosteroids on a daily basis up to the time of lung transplantation. All infants received concomitant narcotic and benzodiazepine infusions throughout the study period. No pulmonary vasodilators were used. A day of neuromuscular blockade was one in which the agents were administered for more than 18 consecutive hours. The clinical characteristics and outcomes of the five subjects are listed in Table 1 .
Quantifying Oxygenation
We calculated daily averages for all ventilatory support and blood gas values for the 24-hour period. Arterial blood gas determinations comprised only one third of all blood gas determinations, precluding complete analysis using more informative measures of gas exchange. value. In this manner, the greater number of available FiO 2 values throughout the day limited the potential of a single blood gas determination or a single subject influencing the data. The mean daily FiO 2 was plotted against the corresponding day of life for each patient. All epochs of HFOV without neuromuscular blockade and HFOV with neuromuscular blockade were analyzed. Regression analysis was then performed for each epoch, calculating the beginning and the ending FiO 2 from each regression equation (Figure 1 ). The changes in FiO 2 per epoch were averaged with respect to neuromuscular blockade status for each patient. These data were normally distributed, so one-sample t-tests were then used to determine if the mean change in FiO 2 with respect to neuromuscular blockade status was significantly different from 0. Analysis of variance was used to compare the calculated mean change in FiO 2 with and without neuromuscular blockade within the group. The lengths of the epochs were variable, so we also performed withingroup analyses for the daily changes in FiO 2 with respect to neuromuscular blockade status. 7 Quantifying Chest Radiographic Appearance As part of routine care, chest radiographs were obtained daily to assess lung expansion. Thus, we obtained radiographs from the beginning and end of each epoch of neuromuscular blockade for o Lung aeration score 1, severe, dense opacification of lungs 2, opacification of the majority of the total lung fields, but interface between lung and diaphragm and / or heart is preserved 3, numerous areas of coalescent opacification amounting to not more than one half of the total lung fields 4, faint granular opacities with only occasional or no air bronchograms 5, normal o Expansion -to -aeration ( E / A ) index = lung expansion score / lung aeration score King et al. HFOV for SP-B Deficiency each patient, approximately 4 to 10 films per patient. One infant's films were unavailable for analysis. The films were randomly reviewed by a single radiologist (G. D. S.) who was unaware of the patient's age or neuromuscular blockade status. Because lung expansion alone did not describe a radiograph's appearance, the radiologist also assessed the degree of aeration of the lung fields and developed a ratio of expansion to aeration (E/A) ( Table 2) . A larger E/A ratio corresponded to a worse radiograph. One-sample t-tests were used to determine if the mean changes in the E/A ratio within epochs were significantly different from 0. Analysis of variance was used to compare the mean changes in the E/A ratio with and without neuromuscular blockade within this group of patients. All data are presented as means (SD). Statistical analyses were performed using Statview Version 4.5 and SuperANOVA for Macintosh computers (Abacus Concepts, Berkeley, CA). The study was approved by the Washington University Human Studies Committee.
RESULTS
The total duration of HFOV and neuromuscular blockade was 67 (SD 31) days and 40 (SD 12) days, respectively. The mean lengths of the individual epochs without and with neuromuscular blockade were not significantly different, 8 (SD 15) days and 9 (SD 6) days, respectively (p=0.8) ( Table 3) .
Oxygenation
FiO 2 consistently increased, mean 0.20 (SD 0.11), during 14 epochs of 2 to 58 days duration without neuromuscular blockade (p=0.02) and consistently decreased 0.14 (SD 0.11) during 20 epochs of 2 to 27 days duration with neuromuscular blockade (p=0.05). These changes in FiO 2 with respect to neuromuscular blockade were significantly different (p=0.01) ( Table 3) . When controlling for the duration of the epochs, comparisons of daily changes in FiO 2 with respect to neuromuscular blockade status yielded results comparable to those above (Table 3) .
Chest Radiographs
Representative chest radiographs for one infant at the end of epochs without and with neuromuscular blockade are shown in Figure 2 . The mean expansion/aeration index increased by a score of 2.0 (SD 2.0) during epochs without neuromuscular blockade (p=0.01) and decreased by a score of 1.9 (SD 2.6) during epochs with neuromuscular blockade (p=0.03, and p=0.001 with respect to neuromuscular blockade status). The change in radiograph score correlated with the change in oxygenation, (p<0.001) (Figure 3 ).
DISCUSSION
Strategies to prevent pulmonary dysfunction and the resulting extrapulmonary organ complications in the pretransplantation period are essential to maximize the likelihood that SP-B-deficient infants will survive the unpredictable waiting period until lung transplantation and to optimize their outcome following transplantation. We have shown with two independent markers (FiO 2 as proxy for oxygenation and chest radiographic appearance) that HFOV combined with intermittent neuromuscular blockade appears to be more effective in maintaining pulmonary function than HFOV alone for SP-B-deficient infants. Although we performed similar analyses for the SP-B-deficient infants receiving conventional ventilation with and without neuromuscular blockade, too few epochs were available to reach any conclusions. Our experience has suggested, however, that conventional ventilation, irrespective of neuromuscular blockade status, is not as effective as HFOV in maintaining oxygenation. 1, 5, 6 Small numbers of SP-B-deficient infants, the retrospective nature of the analysis, and the difficulty of finding equivalent comparison groups are several limitations of this study. Because we were limited to observation in a group of infants with a unique clinical presentation we cannot determine if these findings can be generalized to other critically ill patients. In addition, changing conditions could lead to clinical interventions that stabilized gas exchange irrespective of ventilatory and/or neuromuscular blockade strategy. Three of the infants received corticosteroid therapy during the study period; however, no apparent clinical response was observed, which confirms earlier observations. 2, 4 Similar analyses of gas exchange and chest radiographs for SP-B-deficient infants from several institutions should be performed to determine if the responses we observed were unique to SP-B deficiency and not simply a manifestation of experienced and consistent care delivery.
HFOV and neuromuscular blockade may improve gas exchange regardless of the underlying mechanism of pulmonary dysfunction. HFOV effectively recruits alveoli and will have a more apparent effect on gas exchange in a patient with homogeneous lung disease. 8 Furthermore, neuromuscular blockade itself may improve pulmonary mechanics by decreasing pulmonary resistance, though several investigators have demonstrated diminished oxygenation, FRC, and compliance after administration of pancuronium and morphine to infants with hyaline membrane disease who were receiving conventional ventilation. 9 -11 More speculatively, when compared with conventional ventilation, inflammatory mediators such as 15-hydroxyeicosatetraenoic acid, platelet-activating factor, thromboxane B 2 , and tumor necrosis factor-were present in lower amounts in surfactant-depleted rabbits who received HFOV. 12 -14 In the presence of preexisting lung injury, HFOV with neuromuscular blockade may decrease the contribution of these inflammatory mediators to pulmonary dysfunction. Although these alternative hypotheses may explain improvements in gas exchange, none would account for the significant improvements in chest radiographic appearance we found with the SP-B-deficient infants during neuromuscular blockade.
We believe that a more fundamental mechanism may explain our observations. The cycle of alveolar distention and relaxation stimulates surfactant secretion. 15 -19 We speculate that the combination of HFOV with neuromuscular blockade eliminates alveolar excursion and prevents the secretion and/or accumulation of dysfunctional SP-B-deficient surfactant in the alveolar space. The absence of alveolar proteinosis in the SP-B-deficient infants who have been treated with HFOV provides indirect evidence for this hypothesis. 4 Further indirect support for this speculation is derived from studies evaluating surfactant composition with respect to HFOV and conventional ventilation. When compared with conventional ventilation, lung lavage fluid from preterm lambs undergoing HFOV contained less SP-A and phosphatidylcholine. 20 Furthermore, in infants with lung disease, the concentration of phospholipid and DSPC increased significantly when they were changed from HFOV to conventional ventilation. 21 Whether spontaneous respiration during HFOV leads to comparable changes in pulmonary surfactant is unclear. Although unquantifiable, the infants in this study did breathe spontaneously during epochs without neuromuscular blockade. The rate and depth of spontaneous respiratory efforts could influence the gas exchange and radiographic observations of this study. The use of stable isotopes to measure surfactant turnover during HFOV with and without neuromuscular blockade may provide biochemical support for the observations made in this study. 22, 23 Prompt diagnosis, timely referral to a pediatric lung transplantation center, and application of effective ventilatory strategies, such as HFOV with intermittent neuromuscular blockade, will increase the likelihood of intact survival until lung transplantation can be performed for SP-B-deficient infants. Although prospective studies need to be completed to fully understand the implications of HFOV with neuromuscular blockade, one could consider this ventilatory strategy whenever the diagnosis of SP-B deficiency is being entertained and while awaiting confirmatory studies. 
